CurrentCardio
Get Weekly

CurrentCardio coverage · page 5 of 11

JACC: Cardiovascular Interventions

Briefs 161–200 of 433 CurrentCardio has covered from this journal, newest publication first

Latest from JACC: Cardiovascular Interventions

All coverage, newest first

  1. JACC Cardiovasc Interv

    Transcatheter Edge-to-Edge Repair for Atrial and Ventricular Secondary Mitral Regurgitation: Insights From the REPAIR Study

    Cohort studyValvular & structural

  2. JACC Cardiovasc Interv

    Early Outcomes of Real-World Transcatheter Tricuspid Valve Replacement

    Cohort studyValvular & structural

  3. JACC Cardiovasc Interv

    Prosthesis-Patient Mismatch in Young and Low-Risk Patients After Newer Generation Balloon-Expandable Transcatheter Aortic Valve Replacement

    Cohort studyValvular & structural

  4. JACC Cardiovasc Interv

    Cost-Effectiveness of Early Discharge (<48 Hours) for Low-Risk Patients Following PPCI for STEMI

    Cohort studyCoronary & ACS

  5. JACC Cardiovasc Interv

    The Coronary Access After TAVI (CAvEAT) Study: A Prospective Registry of CA After TAVR

    Cohort studyValvular & structural

  6. JACC Cardiovasc Interv

    15-Year Outcomes of PFO Closure in Patients With Cryptogenic Embolism: Insights From the PROLONG Registry

    Cohort studyValvular & structural

  7. JACC Cardiovasc Interv

    Aortic Valve Replacement in Women: A Pooled Analysis of the RHEIA and PARTNER 3 Trials

    Meta-analysisValvular & structural

  8. JACC Cardiovasc Interv

    Ventricular Interaction and Clinical Outcomes in Patients Undergoing Transcatheter Tricuspid Valve Repair

    Cohort studyValvular & structural

  9. JACC Cardiovasc Interv

    Procedural Impact of Advanced Calcific Plaque Modification Devices Within Percutaneous Revascularization of Chronic Total Occlusions

    Cohort studyCoronary & ACS

  10. JACC Cardiovasc Interv

    Heterotopic Crosscaval Transcatheter Tricuspid Valve Replacement for Patients With Tricuspid Regurgitation: The Trillium Device

    Research articleValvular & structural

  11. JACC Cardiovasc Interv

    Right Ventricular–Pulmonary Artery Coupling in Tricuspid Regurgitation: Prognostic Value and Impact of Treatment Strategy

    Cohort studyValvular & structural

  12. JACC Cardiovasc Interv

    Tricuspid Regurgitation and 3-Year Mortality After Transseptal Mitral Valve-in-Valve Replacement

    Cohort studyValvular & structural

  13. JACC Cardiovasc Interv

    3-Year Outcomes of Mitral Valve-in-Valve Therapy Using Balloon-Expandable Transcatheter Valves in the United States

    Cohort studyValvular & structural

  14. JACC Cardiovasc Interv

    Aspirin vs Clopidogrel 1 Month After Acute Coronary Syndrome With High-Bleeding Risk or ST-Segment Elevation

    Secondary analysisCoronary & ACS

  15. JACC Cardiovasc Interv

    PFO Device Closure in Patients >60 Years of Age With Ischemic Stroke: Results From U.S. Medicare Beneficiaries

    Cohort study

  16. JACC Cardiovasc Interv

    Transcatheter Edge-to-Edge Repair in Patients With Primary Tricuspid Regurgitation

    Cohort studyValvular & structural

  17. JACC Cardiovasc Interv

    Clinical Effectiveness of Transcatheter Left Atrial Appendage Occlusion With Watchman FLX Compared With First-Generation Watchman

    Cohort studyArrhythmias & EP

  18. JACC Cardiovasc Interv

    Revascularization Strategies in ST-Segment Elevation Myocardial Infarction With Multivessel Disease: Temporal Trends, Patient Profiles, and Outcomes

    Cohort studyCoronary & ACS

  19. JACC Cardiovasc Interv

    Prognostic Value of Microvascular Function in Takotsubo Syndrome: A Pooled Analysis of Individual Patient Data

    Meta-analysisHeart failure

  20. JACC Cardiovasc Interv

    Outcomes of Percutaneous Coronary Intervention for Chronic Total Occlusion With Bifurcation at Distal Cap

    Cohort studyCoronary & ACS

  21. JACC Cardiovasc Interv

    Intravascular Ultrasound Assessment of Coronary Arteries at High Risk for Obstruction Following TAVR: The ICARO Study

    Cohort studyValvular & structural

  22. JACC Cardiovasc Interv

    Risk of Coronary Obstruction in Redo-Transcatheter Aortic Valve Replacement Between Bicuspid and Tricuspid Aortic Valves

    Research articleValvular & structural

  23. JACC Cardiovasc Interv

    Transcatheter Aortic Valve Replacement With Intra-Annular Self-Expanding or Balloon-Expandable Valves: The Multicenter International NAVULTRA Registry

    Cohort studyValvular & structural

  24. JACC Cardiovasc Interv

    Clinical Impact of Midframe Underexpansion Following TAVR Using a Self-Expanding Transcatheter Heart Valve

    Cohort studyValvular & structural

  25. JACC Cardiovasc Interv

    Association Between Myocardial Infarction and Quality of Life in the ISCHEMIA Trial

    Secondary analysisCoronary & ACS

  26. JACC Cardiovasc Interv

    Proportion and Clinical Impact of Stent Optimization During Imaging-Guided Percutaneous Coronary Intervention: The OCTIVUS Trial

    Secondary analysisCoronary & ACS

  27. JACC Cardiovasc Interv

    Factors Associated With Chronic Stent Recoil and its Impact on Revascularization: A Serial Optical Coherence Tomography Study

    Cohort studyCoronary & ACS

  28. JACC Cardiovasc Interv

    Cangrelor During Percutaneous Coronary Intervention in Patients With Cardiogenic Shock or Cardiac Arrest

    Cohort studyAcute care & resuscitation

  29. JACC Cardiovasc Interv

    Surgical Mitral Valve Repair vs Replacement After Failed Mitral Transcatheter Edge-to-Edge Repair: The CUTTING-EDGE Registry

    Cohort studyValvular & structural

  30. JACC Cardiovasc Interv

    Transcatheter Tricuspid Valve Replacement With the Novel System: 1-Year Outcomes From the TRAVEL Study

    Cohort studyValvular & structural

  31. JACC Cardiovasc Interv

    Left Main Spontaneous Coronary Artery Dissection: Clinical Features, Management, and Outcomes

    Meta-analysisCoronary & ACS

  32. JACC Cardiovasc Interv

    Long-Term Outcomes of Patients Requiring Pacemaker Implantation After Transcatheter Aortic Valve Replacement: The SwissTAVI Registry

    Cohort studyValvular & structural

  33. JACC Cardiovasc Interv

    Development of a Novel BifurcAID Risk Score to Predict MACE Following Coronary True Bifurcation Intervention

    Cohort studyCoronary & ACS

  34. JACC Cardiovasc Interv

    Diabetic Status and Thrombogenicity: Association and Prognostic Implications After Percutaneous Coronary Intervention

    Cohort studyCoronary & ACS

  35. JACC Cardiovasc Interv

    Different Mechanical Circulatory Support Strategies for Infarct-Related Cardiogenic Shock: A Subanalysis of the ECLS-SHOCK Trial

    Secondary analysisAcute care & resuscitation

  36. JACC Cardiovasc Interv

    Early Results of Multicenter Trial of a Novel Balloon-Expandable Valve With Anchor for Aortic Regurgitation

    Cohort studyValvular & structural

  37. JACC Cardiovasc Interv

    Initial Experience and Bench Validation of the CLEVE Prosthetic Leaflet Modification Procedure During Aortic and Mitral Valve-in-Valve Procedures

    Diagnostic or prognostic studyValvular & structural

  38. JACC Cardiovasc Interv

    Smoking Status at Baseline and 10-Year Outcomes After Drug-Eluting Stent Implantation: Insights From the DECADE Cooperation

    Meta-analysisCoronary & ACS

  39. JACC Cardiovasc Interv

    Transcatheter Pulmonary Valve Implantation Using Self-Expandable Percutaneous Pulmonary Valve System: 3-Year CE Study Results

    Cohort studyCongenital

  40. JACC Cardiovasc Interv

    Temporal Trends in 1-Year Cause-Specific Mortality After TAVR: Insights From the STS/ACC TVT Registry

    Cohort studyValvular & structural

All 433 Briefs in ExploreShowing Briefs 161–200 of 433, newest first